LEADER 02762oam  2200697   450 
001 9910716666803321
005 20220407094111.0
035   $a(CKB)5470000002523496
035   $a(OCoLC)1259367164
035   $a(EXLCZ)995470000002523496
100   $a20210707d2019      ua             0
101 0 $aeng
135   $aurbn||||a||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aOpportunities to improve the 340B drug pricing program $ehearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, second session, July 11, 2018
210  1$aWashington :$cU.S. Government Publishing Office,$d2019.
215   $a1 online resource (v, 172 pages)
300   $a"Serial no. 115-147."
320   $aIncludes bibliographical references.
327   $tDrug discount program: improvements needed in federal oversight of compliance at 340B contract pharmacies.
517   $aOpportunities to improve the 340B drug pricing program 
606   $aPoor$xPharmaceutical assistance$zUnited States
606   $aPharmaceutical services$xEconomic aspects$zUnited States
606   $aPrescription pricing$xGovernment policy$zUnited States
606   $aFederal aid to health facilities$zUnited States
606   $aDrug accessibility$xGovernment policy$zUnited States
606   $aHospitals$zUnited States$xFinance
606   $aCustomer services$2fast
606   $aFederal aid to health facilities$2fast
606   $aHospitals$xFinance$2fast
606   $aPharmaceutical services$xEconomic aspects$2fast
606   $aPoor$xPharmaceutical assistance$2fast
606   $aPrescription pricing$xGovernment policy$2fast
607   $aUnited States$2fast
608   $aLegislative hearings.$2fast
608   $aLegislative hearings.$2lcgft
615  0$aPoor$xPharmaceutical assistance
615  0$aPharmaceutical services$xEconomic aspects
615  0$aPrescription pricing$xGovernment policy
615  0$aFederal aid to health facilities
615  0$aDrug accessibility$xGovernment policy
615  0$aHospitals$xFinance.
615  7$aCustomer services.
615  7$aFederal aid to health facilities.
615  7$aHospitals$xFinance.
615  7$aPharmaceutical services$xEconomic aspects.
615  7$aPoor$xPharmaceutical assistance.
615  7$aPrescription pricing$xGovernment policy.
801  0$bGPO
801  1$bGPO
801  2$bGPO
801  2$bOCLCO
801  2$bOCLCF
801  2$bOCLCQ
801  2$bGPO
906   $aBOOK
912   $a9910716666803321
996   $aOpportunities to improve the 340B drug pricing program$93498246
997   $aUNINA